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Background
The Epidermal Growth Factor Receptor (EGFR) is a
transmembrane receptor tyrosine kinase with critical
implications in cell proliferation, migration, wound heal-
ing and the regulation of apoptosis. However, the EGFR
has been shown to be hyper-expressed in a number of
human malignancies. The MDA-MB-468 metastatic
breast cell line is one example of this. This particular
cell line hyper-expresses the EGFR and undergoes EGFR
mediated apoptosis in response to EGF ligand. Previous
studies within our laboratory have shown that when the
EGFR is activated and retained at the cell membrane,
MDA-MB-468 cells undergo cell growth. Conversely,
once the activated EGFR is internalized within endo-
somes, the cells undergo apoptosis [1]. This contrasting
response at subcellular locations is defined as spatial
regulation. The goal of this project is to identify the
kinases responsible for the induction of apoptosis from
within the endosomes. Research has shown that cGMP
dependent protein kinase (PKG) activation within this
cell line induces apoptosis in a dose dependent manner
[2]. We hypothesize that PKG plays an intermediate role
in the EGFR induction of apoptosis.
Conclusion
The data confirm that PKG activation induces cell death
within the MDA-MB-468 cell line. PKG activity is also
correlated to, and downstream of EGFR activation.
Future studies entail inhibiting PKG activity in order to
determine its individual role in mediating EGFR-induced
apoptosis.
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